SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMYLIN PHARM.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: luis a. garcia who wrote (38)1/17/1997 9:34:00 PM
From: Eric Klein   of 52
 
Thanks for the info. I got into AMLN when it dipped (on no news) in July. If their diabetes treatment proves out, which it looks like it will, this could be a goldmine. Diabetics who inject insulin have tremendous problems. If every shot of insulin is mixed with pramlinitude...

Likely it will drop back down somewhat, but I'd be surprised if it falls below 12 unless some big disaster hits. If you're waiting for it to fall to 11 before buying, you may have a long wait.

For what it's worth, Michael Murphy (California Technology Stock Newsletter) has a buy on it, but the way some of his rec's go, that may not be a good reason to buy.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News